2型糖尿病患者に対する高用量メトホルミンの臨床効果の検討

書誌事項

タイトル別名
  • Efficacy of High-Dose Metformin in Type 2 Diabetes Mellitus
  • 2ガタ トウニョウビョウ カンジャ ニ タイスル コウヨウリョウ メトホルミン ノ リンショウ コウカ ノ ケントウ

この論文をさがす

抄録

The maximal dose of metformin is limited to 750mg/day in Japan.To evaluate the efficacy of high dose metformin, we administrated 1500mg/day for 12 weeks in 12 type-2 diabetic patients whose HbA1c exceeded 7.0% with 750mg/day. Fasting plasma glucose, HbA1c, plasma insulin, and insulin resistance index of homeostasis model assessment decreased significantly from 194±42mg/dl, 8.2±1.1%, 9.3±2.6mUml, and 4.27±1.14 to 165±28, 7.5±0.9, 7.5±3.1, and 2.95±1.36 with the increased dose. No significant change was detected in serum lactate. Although half of patients had gastrointestinal symptoms such as diarrhea, abdominal bloating, and constipation, symptoms were mild and disappeared within a week.These results indicate that high-dose metformin is effective in patients with inadequate low dose glycemic control.

収録刊行物

  • 糖尿病

    糖尿病 46 (5), 399-402, 2003

    一般社団法人 日本糖尿病学会

被引用文献 (5)*注記

もっと見る

参考文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ